Improved fibrinolysis by an intensive lifestyle intervention in subjects with impaired glucose tolerance. The Finnish Diabetes Prevention Study

Diabetologia

Volumn 48, Issue 11, 2005, Pages 2248-2253

  Hamalainen H ^a   Ronnemaa T ^b   Virtanen, A ^a   Lindstrom J ^c   Eriksson, J G ^c   Valle, T T ^c   Ilanne Parikka, P ^d   Keinanen Kiukaanniemi S ^e   Rastas, M ^c   Aunola, S ^c   Uusitupa, M ^f   Tuomilehto, J ^c,g  

^a SOCIAL INSURANCE INSTITUTION   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

^c NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^d Finnish Diabetes Association   (Finland)

^e UNIVERSITY OF OULU   (Finland)

^f UNIVERSITY OF EASTERN FINLAND   (Finland)

^g UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Diet; DPS; Fibrinogen; Impaired glucose tolerance; Lifestyle; Physical activity; Plasminogen activator inhibitor; Weight

Indexed keywords

FIBRINOGEN; GLUCOSE; PLASMINOGEN ACTIVATOR INHIBITOR 1;

ADULT; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DIET THERAPY; FIBRINOGEN BLOOD LEVEL; FOLLOW UP; HEALTH PROGRAM; HEALTH PROMOTION; HUMAN; IMPAIRED GLUCOSE TOLERANCE; LIFESTYLE; MAJOR CLINICAL STUDY; MEDICAL ASSESSMENT; PATIENT ATTITUDE; PATIENT EDUCATION; PHYSICAL ACTIVITY; PRIORITY JOURNAL; RISK REDUCTION; WEIGHT REDUCTION;

ADULT; DIABETES MELLITUS; DIABETES MELLITUS, TYPE 2; DIET; EXERCISE; FEMALE; FIBRINOGEN; FIBRINOLYSIS; FINLAND; FOLLOW-UP STUDIES; GLUCOSE INTOLERANCE; HUMANS; LIFE STYLE; MALE; MIDDLE AGED; PLASMINOGEN ACTIVATOR INHIBITOR 1; WEIGHT LOSS;

EID: 27744600828     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-005-1938-5     Document Type: Article

References (48)

1. Haffner SM, Lehto S, Rönnemaa T, Pyörälä K, Laakso M (1998) Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 339:229-234
2. Kannel WB, McGee DL (1979) Diabetes and glucose tolerance as risk factors for cardiovascular disease: the Framingham study. Diabetes Care 2:120-126
3. Qiao Q, Jousilahti P, Eriksson J, Tuomilehto J (2003) Predictive properties of impaired glucose tolerance for cardiovascular risk are not explained by the development of overt diabetes during follow-up. Diabetes Care 26:2910-2914
4. Kuller LH, Velentgas P, Barzilay J, Beauchamp NJ, O'Leary DH, Savage PJ (2000) Diabetes mellitus: subclinical cardiovascular disease and risk of incident cardiovascular disease and all-cause mortality. Arterioscler Thromb Vasc Biol 20:823-829
5. Ernst E, Resch KL (1993) Fibrinogen as a cardiovascular risk factor: a meta-analysis and review of the literature. Ann Intern Med 118:956-963
6. Ceriello A (1997) Fibrinogen and diabetes mellitus: is it time for intervention trials? Diabetologia 40:731-734
7. Kannel WB, D'Agostino RB, Wilson PW, Belanger AJ, Gagnon DR (1990) Diabetes, fibrinogen, and risk of cardiovascular disease: the Framingham experience. Am Heart J 120:672-676
8. Haffner SM, D'Agostino R Jr, Festa A et al (2003) Low insulin sensitivity (S(i)=0) in diabetic and nondiabetic subjects in the insulin resistance atherosclerosis study: is it associated with components of the metabolic syndrome and nontraditional risk factors? Diabetes Care 26:2796-2803
9. Lam TH, Liu LJ, Janus ED, Lam KS, Hedley AJ (2000) Fibrinogen, other cardiovascular risk factors and diabetes mellitus in Hong Kong: a community with high prevalence of Type 2 diabetes mellitus and impaired glucose tolerance. Diabet Med 17:798-806
10. Juhan-Vague I, Alessi MC, Vague P (1996) Thrombogenic and fibrinolytic factors and cardiovascular risk in non-insulin-dependent diabetes mellitus. Ann Med 28:371-380
11. Meigs JB, Mittleman MA, Nathan DM et al (2000) Hyperinsulinemia, hyperglycemia, and impaired hemostasis: the Framingham Offspring Study. JAMA 283:221-228
12. Nagi DK, Mohamed Ali V, Jain SK, Walji S, Yudkin JS (1996) Plasminogen activator inhibitor (PAI-1) activity is elevated in Asian and Caucasian subjects with non-insulin-dependent (type 2) diabetes but not in those with impaired glucose tolerance (IGT) or non-diabetic Asians. Diabet Med 13:59-64
13. Eliasson MC, Jansson JH, Lindahl B, Stegmayr B (2003) High levels of tPA antigen precede the development of type 2 diabetes in a longitudinal population study. The Northern Sweden MONICA Study. Cardiovasc Diabetol 2:19
14. Haffner SM (2003) Insulin resistance, inflammation, and the prediabetic state. Am J Cardiol 92:18J-26J
15. Lee KW, Lip GY (2003) Effects of lifestyle on hemostasis, fibrinolysis, and platelet reactivity: a systematic review. Arch Intern Med 163:2368-2392
16. El-Sayed MS, Sale C, Jones PG, Chester M (2000) Blood hemostasis in exercise and training. Med Sci Sports Exerc 32:918-925
17. Rissanen P, Vahtera E, Krusius T, Uusitupa M, Rissanen A (2001) Weight change and blood coagulability and fibrinolysis in healthy obese women. Int J Obes Relat Metab Disord 25:212-218
18. Marckmann P, Toubro S, Astrup A (1998) Sustained improvement in blood lipids, coagulation, and fibrinolysis after major weight loss in obese subjects. Eur J Clin Nutr 52:329-333
19. Hamdy O, Ledbury S, Mullooly C et al (2003) Lifestyle modification improves endothelial function in obese subjects with the insulin resistance syndrome. Diabetes Care 26:2119-2125
20. Lindahl B, Nilsson TK, Jansson JH, Asplund K, Hallmans G (1999) Improved fibrinolysis by intense lifestyle intervention. A randomized trial in subjects with impaired glucose tolerance. J Intern Med 246:105-112
21. Torjesen PA, Birkeland KI, Anderssen SA, Hjermann I, Holme I, Urdal P (1997) Lifestyle changes may reverse development of the insulin resistance syndrome. The Oslo Diet and Exercise Study: a randomized trial. Diabetes Care 20:26-31
22. Tuomilehto J, Lindström J, Eriksson JG et al (2001) Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 344:1343-1350
23. Eriksson J, Lindström J, Valle T et al (1999) Prevention of Type II diabetes in subjects with impaired glucose tolerance: the Diabetes Prevention Study (DPS) in Finland. Study design and 1-year interim report on the feasibility of the lifestyle intervention programme. Diabetologia 42:793-801
24. Lindström J, Louheranta A, Mannelin M et al (2003) The Finnish Diabetes Prevention Study (DPS): lifestyle intervention and 3-year results on diet and physical activity. Diabetes Care 26:3230-3236
25. World Health Organization Expert Committee (1985) Diabetes mellitus. WHO, Geneva
26. Ovaskainen M-L, Valsta L, Lauronen J (1996) The compilation of food analysis values as a database for dietary values: the Finnish experience. Food Chem 57:133-136
27. Lakka TA, Salonen JT (1992) Intra-person variability of various physical activity assessments in the Kuopio Ischaemic Heart Disease Risk Factor Study. Int J Epidemiol 21:467-472
28. Laaksonen DE, Lindström J, Lakka TA et al (2005) Physical activity in the prevention of type 2 diabetes: the Finnish Diabetes Prevention Study. Diabetes 54:158-165
29. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419
30. Mavri A, Alessi MC, Bastelica D et al (2001) Subcutaneous abdominal, but not femoral fat expression of plasminogen activator inhibitor-1 (PAI-1) is related to plasma PAI-1 levels and insulin resistance and decreases after weight loss. Diabetologia 44:2025-2031
31. Mavri A, Stegnar M, Krebs M, Sentocnik JT, Geiger M, Binder BR (1999) Impact of adipose tissue on plasma plasminogen activator inhibitor-1 in dieting obese women. Arterioscler Thromb Vasc Biol 19:1582-1587
32. Folsom AR, Qamhieh HT, Wing RR et al (1993) Impact of weight loss on plasminogen activator inhibitor (PAI-1), factor VII, and other hemostatic factors in moderately overweight adults. Arterioscler Thromb 13:162-169
33. Turpeinen AM, Juntunen K, Mutanen M, Mykkänen H (2000) Similar responses in hemostatic factors after consumption of wholemeal rye bread and low-fiber wheat bread. Eur J Clin Nutr 54:418-423
34. Marckmann P, Sandström B, Jespersen J (1993) Favorable long-term effect of a low-fat/high-fiber diet on human blood coagulation and fibrinolysis. Arterioscler Thromb 13:505-511
35. Marckmann P, Sandström B, Jespersen J (1992) Fasting blood coagulation and fibrinolysis of young adults unchanged by reduction in dietary fat content. Arterioscler Thromb 12:201-205
36. Niskanen L, Schwab US, Sarkkinen ES, Krusius T, Vahtera E, Uusitupa MI (1997) Effects of dietary fat modification on fibrinogen, factor VII, and plasminogen activator inhibitor-1 activity in subjects with impaired glucose tolerance. Metabolism 46:666-672
37. Giannopoulou I, Ploutz-Snyder LL, Carhart R et al (2005) Exercise is required for visceral fat loss in postmenopausal women with type 2 diabetes. J Clin Endocrinol Metab 90:1511-1518
38. Cigolini M, Targher G, Bergamo Andreis IA, Tonoli M, Agostino G, De Sandre G (1996) Visceral fat accumulation and its relation to plasma hemostatic factors in healthy men. Arterioscler Thromb Vasc Biol 16:368-374
39. Janand-Delenne B, Chagnaud C, Raccah D, Alessi MC, Juhan-Vague I, Vague P (1998) Visceral fat as a main determinant of plasminogen activator inhibitor 1 level in women. Int J Obes Relat Metab Disord 22:312-317
40. Svendsen OL, Hassager C, Christiansen C, Nielsen JD, Winther K (1996) Plasminogen activator inhibitor-1, tissue-type plasminogen activator, and fibrinogen: effect of dieting with or without exercise in overweight postmenopausal women. Arterioscler Thromb Vasc Biol 16:381-385
41. El-Sayed MS (1996) Effects of high and low intensity aerobic conditioning programs on blood fibrinolysis and lipid profile. Blood Coagul Fibrinolysis 7:484-490
42. Stratton JR, Chandler WL, Schwartz RS et al (1991) Effects of physical conditioning on fibrinolytic variables and fibrinogen in young and old healthy adults. Circulation 83:1692-1697
43. Rauramaa R, Väisänen SB (1999) Physical activity in the prevention and treatment of a thrombogenic profile in the obese: current evidence and research issues. Med Sci Sports Exerc 31:S631-S634
44. Vanninen E, Laitinen J, Uusitupa M (1994) Physical activity and fibrinogen concentration in newly diagnosed NIDDM. Diabetes Care 17:1031-1038
45. Ponjee GA, Janssen GM, van Wersch JW (1993) Prolonged endurance exercise and blood coagulation: a 9 month prospective study. Blood Coagul Fibrinolysis 4:21-25
46. Zanettini R, Bettega D, Agostoni O et al (1997) Exercise training in mild hypertension: effects on blood pressure, left ventricular mass and coagulation factor VII and fibrinogen. Cardiology 88:468-473
47. Schuit AJ, Schouten EG, Kluft C, de Maat M, Menheere PP, Kok FJ (1997) Effect of strenuous exercise on fibrinogen and fibrinolysis in healthy elderly men and women. Thromb Haemost 78:845-851
48. Haffner S, Temprosa M, Crandall J et al (2005) Intensive life-style intervention or metformin on inflammation and coagulation in participants with impaired glucose tolerance. Diabetes 54:1566-1572